142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

310000
High and low pMTCT performance: The role of facility-level factors in Côte d'Ivoire, Kenya, and Mozambique

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Wednesday, November 19, 2014 : 9:18 AM - 9:30 AM

Alison S. Rustagi, PhD , Department of Global Health, University of Washington, Seattle, WA
Sarah Gimbel, PhD, MPH, RN , School of Nursing, University of Washington, Seattle, WA
Ruth Nduati, MBChB, MMed, MPH , Department of Pediatrics & Child Health, University of Nairobi, Nairobi, Kenya
Maria de Fatima Cuembelo, MD, MPH , School of Medicine, Eduardo Mondlane University, Maputo, Mozambique
Judith Wasserheit, MD, MPH , Department of Global Health, Department of Medicine, University of Washington, Seattle, WA
Carey Farquhar, MD, MPH , Department of Medicine, Department of Epidemiology, Department of Global Health, University of Washington, Seattle, WA
Stephen Gloyd, MD, MPH , Department of Global Health, University of Washington, Seattle, WA
Kenneth Sherr, PhD, MPH , Department of Global Health, University of Washington, Seattle, WA
Background: Services to prevent mother-to-child transmission (pMTCT) of HIV require well-functioning health facilities to realize the vision of an HIV-free generation. This study aimed to identify health facility characteristics associated with high pMTCT performance in three sub-Saharan African countries. 

Methods: Ninety antenatal care (ANC) facilities were sampled in Côte d’Ivoire, Kenya, and Mozambique and ranked based on pMTCT performance in 2012 (defined as the proportion of pregnant women tested for HIV at first ANC visit (ANC1), multiplied by the proportion of HIV-positive pregnant women on dual or triple anti-retroviral regimens). The top and bottom 10 facilities per country were defined as “high” and “low” performers, respectively. Facility characteristics were ascertained during on-site visits. Binomial regression quantified associations between facility factors and performance.

Results: Sixty ANC facilities were included. High performance was associated with high clinic volume (RR per 100 ANC1 visits=1.05, 95% CI: 1.03-1.07), high staffing levels (RR per midwife=1.05, 95% CI: 1.04-1.07; RR per physician=1.04, 95% CI: 1.03-1.06), and on-site CD4 testing services (RR=2.00, 95% CI: 1.28-3.11). Other characteristics – including year of pMTCT initiation, support groups, active tracing of patients lost to follow-up, and HIV test or zidovudine stock-outs over 3 months – were not associated with performance.

Conclusions: Staffing levels, on-site CD4 testing, and patient volume were associated with high pMTCT performance. Several services – such as support groups and active tracing – were common in both high- and low-performing clinics. A ranking system based on routinely available data can highlight modifiable characteristics to maximize pMTCT effectiveness.

Learning Areas:

Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs

Learning Objectives:
Describe a system of ranking health facilities in terms of pMTCT performance using routinely-available health information. Identify characteristics of health facilities associated with high pMTCT performance in sub-Saharan Africa.

Keyword(s): Maternal and Child Health, Performance Measurement

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I conducted the analysis for the abstract submitted. I have been involved in several other projects related to health systems strengthening in sub-Saharan Africa, and I have completed a case-control study from conception, to publication (including study design, data collection, and data analysis).
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.